Industry Member

PhRMA, the Pharmaceutical Research and Manufacturers of America, represents the country’s leading biopharmaceutical researchers and biotechnology companies.

Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as Cancer, Alzheimer’s Disease, Cystic Fibrosis and Parkinson’s.

New medicines are an integral part of the healthcare system, providing doctors and their patients with safe and effective treatment options, extending and improving quality of life.

At Twist Bioscience, we work in the service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals, and data storage, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet.

With TE, you get more than just a components supplier. You get an integrated solutions partner who can develop your idea from design to prototype to manufacturing and assembly. The value we provide helps you compete, including:

Engineering expertise — Early design collaboration takes you from concept to production, and more.
Extensive manufacturing capabilities — We create components or fully functional devices where and when you want, including contract manufacturing.
Global footprint — Get better responsiveness and access to emerging markets.
Focus on the […]

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patient’s needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi US, with headquarters in Bridgewater, New Jersey, employs 17,000 professionals throughout the country. Our affiliate companies in the United States include Genzyme (rare diseases), Sanofi Pasteur (vaccines), Merial (animal health) and Chattem (consumer healthcare). Through the Sanofi Foundation for North America, we strive to reduce […]

Our vision is to transform how the world approaches the treatment of serious and life-threatening diseases by unlocking the potential of RNA-based technologies.

Recognizing the complexity of this goal, we focus on rare, infectious and other diseases with tremendous unmet needs—areas in which new therapies have the potential to make dramatic improvements in the lives of patients.

Acer is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. Acer’s product candidates are believed to present a comparatively de-risked profile, having one or more of a favorable safety profile, clinical proof-of-concept data, mechanistic differentiation and/or accelerated paths for development through specific programs and procedures established by the FDA.

AgonOx is focused on the development of immune system modulators in combination with other promising cancer immunotherapies.

APDM’s mission is to develop and commercialize best-in-class solutions for quantifying human movement with wearable technologies. As a first step in this mission, we created the world’s most advanced movement monitors. These range from our premier Opals to our low-cost Sapphires. All of our movement monitors have a full kinematic sensor suite including low-noise triaxial accelerometers, gyroscopes, and magnetometers. To expand on our mission, we developed the first wearable sensor-based gait and balance assessment system, Mobility Lab. This system has […]

Apical LLC is an Ag-tech Company that combines modern analytical methods, eco-friendly growing products and smart data management techniques to provide growers with the tools they need to grow extremely healthy, optimal yielding crops organically with minimal pest problems.

Aronora is a translational biotechnology company engaged in the early-stage commercial development of proprietary biologic therapeutics, including recombinant monoclonal antibodies and enzymes.  Building on the company’s ground-breaking rational approaches to superior drug safety, Aronora’s product candidates have the potential to become first-in-class medical emergency therapeutics to treat life-threatening acute thrombotic vascular diseases early, in the field, even before the patient is hospitalized and the diagnosis is verified.